M. Vinogradov

Dose-response modelling of total haemoglobin mass to hypoxic dose in elite speed skaters

I. Zelenkova, M. Vinogradov, 2020, bioRxiv.

Correlation between development of pulmonary edema and response of pulmonary metastases of metastatic melanoma and kidney cancer to high-dose continuous-infusion interleukin-2.

P. Walker, M. Vinogradov, Nawazish Khan, 2005, Cancer biotherapy & radiopharmaceuticals.

Continuous infusion interleukin-2 and famotidine in metastatic kidney cancer.

P. Walker, D. Liles, M. Vinogradov, 2006, Cancer biotherapy & radiopharmaceuticals.

Activity of continuous infusion plus pulse interleukin-2 with famotidine in patients with metastatic kidney cancer or melanoma previously treated with interleukin-2.

P. Walker, D. Liles, H. Elsamaloty, 2006, Cancer biotherapy & radiopharmaceuticals.

High-dose continuous infusion plus pulse interleukin-2 and famotidine in metastatic kidney cancer.

M. Vinogradov, Nawazish Khan, Chris Taylor, 2005, Cancer biotherapy & radiopharmaceuticals.

Administration of high-dose continuous infusion interleukin-2 to patients age 70 or over.

P. Walker, M. Vinogradov, Chris Taylor, 2005, Cancer biotherapy & radiopharmaceuticals.

High-dose continuous infusion plus pulse interleukin-2 and famotidine in melanoma.

Shawn B. Jackson, M. Vinogradov, Nawazish Khan, 2004, Cancer biotherapy & radiopharmaceuticals.

Repeated cycles with 72-hour continuous infusion interleukin-2 in kidney cancer and melanoma.

M. Vinogradov, Nawazish Khan, R. Burgess, 2004, Cancer biotherapy & radiopharmaceuticals.

Metastatic Porocarcinoma Effectively Managed by Pembrolizumab

M. Vinogradov, Lam Nguyen, Arminder Singh, 2021, Cureus.